K220178

Substantially Equivalent

Total Immunoglobulin E (IgE)

Applicant: Beckman Coulter, Inc.
Product code: DGC
Advisory panel: Immunology
Date received: 2022-01-21
Decision date: 2022-03-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.